BPC-157 is not FDA-approved for any medical condition, including soft-tissue injury, gut healing, pain, inflammation, anti-aging, or performance enhancement
Xpresspost 1-3 business days Essential biotech consumables and materials curated for laboratory R&D and analytical investigation
Clinical Findings of 5-amino-1mq Preclinical studies show improved insulin sensitivity and reduced fat mass in animal models
Storage Store in cool and dry place do not above 25C, protect form light
Pernicious anemia is associated with an increased incidence of carcinoma of the stomach, but this is believed to be related to the underlying pathology and not to treatment with cyanocobalamin
Standard protocols range from 0.25mg to 0.5mg daily via subcutaneous injection for 4 to 8 weeks